Saltar al contenido
Merck

Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitors.

Bioorganic & medicinal chemistry letters (2011-10-07)
Lorin A Thompson, Jianliang Shi, Carl P Decicco, Andrew J Tebben, Richard E Olson, Kenneth M Boy, Jason M Guernon, Andrew C Good, Ann Liauw, Changsheng Zheng, Robert A Copeland, Andrew P Combs, George L Trainor, Daniel M Camac, Jodi K Muckelbauer, Kimberley A Lentz, James E Grace, Catherine R Burton, Jeremy H Toyn, Donna M Barten, Jovita Marcinkeviciene, Jere E Meredith, Charles F Albright, John E Macor
RESUMEN

The synthesis, evaluation, and structure-activity relationships of a set of related constrained diaminopropane inhibitors of BACE-1 are described. The full in vivo profile of an optimized inhibitor in both normal and P-gp deficient mice is compared with data generated in normal rats.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
1,2-Diaminopropane, 99%
Sigma-Aldrich
(S)-(−)-1,2-Diaminopropane dihydrochloride, 99%
Sigma-Aldrich
(R)-(+)-1,2-Diaminopropane dihydrochloride, 99%